EP300 and breast carcinoma: And indeed, in breast cancer, high BRMS1 levels were reported as a marker of poor prognosis.41 In contrast to BRMS1 and p300, the direct analysis of iASPP levels remains to be evaluated regarding its relevance for prognosis and prediction of therapeutic responses, in melanoma and other human malignancies.